The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates in three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment produces and sells titanium dioxide (TiO2) under the Ti-Pure brand name to deliver whiteness, brightness, opacity, and protection in various applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, PVC window profiles, laminate papers, coated paper, and coated paperboard used for packaging. The Fluoroproducts segment provides fluoroproducts, such as hydrofluorocarbon refrigerants, and fluoropolymer resins and downstream products and coatings under the Teflon brand name. The Chemical Solutions segment offers industrial and specialty chemicals used in gold production, oil refining, agriculture, industrial polymers, and other industries in North America. This segment provides cyanides; sulfur products; and performance chemicals and intermediates, such as clean and disinfect chemicals, aniline, methylamines, glycolic acid, Vazo free radical initiators, and reactive metals. The company is headquartered in Wilmington, Delaware.
Chemours -21% after DuPont loses testicular cancer liability case Jul 6 2016, 16:05 ET | By: Carl Surran, Seeking Alpha News Editor Chemours (CC -21.6%) plunged during the final hour of trading after DuPont (DD -1.7%) was found liable for a man’s testicular cancer in a test case involving 3,500 lawsuits over a toxic Teflon chemical found in Ohio and West Virginia waters; although DuPont was found liable, spinoff Chemours must bear the cost. A Columbus, Ohio, jury returned a verdict today that found DuPont responsible for negligence and $5.1M in associated damages; the jury also found actual malice, meaning the company will face punitive damages. In the first related test case last October, a jury awarded $1.6M to a woman who sued over the contamination, and a second case settled on undisclosed terms. Read more: http://seekingalpha.com/news/319201...dupont-loses-testicular-cancer-liability-case
Chemours, DuPont shares spike after court ruling CNBC Shares of Chemours and DuPont spiked Friday after a judge ruled DuPont had to pay an additional $500,000 in punitive damages after being found liable for a man's testicular cancer. Chemours — a DuPont spinoff — traded up about 16 percent, while DuPont had gained 2.5 percent. The punitive damages ruling came two days after a jury awarded a man $5.1 million.
I was able to pick up some July 15 $7.50 calls on Wednesday for 20 cents and just could not believe that CC/DD spiked today based on that news. No complaint though.
